Posters

Extracapsular cataract extraction in chronic severe ocular Stevens–Johnson syndrome: a case report

Poster Details

First Author: M.de Guia PHILIPPINES

Co Author(s):    M. Agdeppa                    

Abstract Details

Purpose:

The purpose of this study is to report the results of performing extracapsular cataract extraction in a middle-aged Filipino female patient with a severe ocular Stevens-Johnson syndrome who had previously undergone multiple ocular procedures relating to the adverse effects of Stevens-Johnson Syndrome, and to discuss its epidemiology, pathogenesis, clinical presentation, treatment, and other issues in the case management.

Setting:

The setting of this case is the urban area of Metro Manila, Philippines in a patient part of the low-income class, seen and managed in a tertiary hospital.

Methods:

This is a case report that was correlated with relevant findings from literature review.

Results:

The case is that of a 40-year old female, diagnosed 4 years prioras a case of Steven-Johnson Syndrome secondary to intake of Trimethoprim/sulfamethoxazole. She had been treated with several lubricant and anti-inflammatory eye drops, as well as underwent conjunctivoplasty, symblepharon release and fine-needle diathermy in order to control the inflammation and severe dryness. She was then diagnosed as a case of cataractous lens (white cataract) and underwent extracapsular cataract extraction. After the procedure, her visual acuity improved from hand movement to 20/40, and inflammation of the cornea and external structures revealed to be controlled even post-operatively.

Conclusions:

As in any case of patients suffering from ocular Stevens-Johnson Syndrome, the decision to perform phacoemulsification when cataract is diagnosed can have varying outcomes. As intraocular surgery can aggravate inflammation, worsening of pre-exsiting symptoms and even visual acuity after surgery may result. Extracapsular cataract extraction can be a safer alternative to the ultrasonics of phacoemulsification and can be considered in patients with this type of chronic illness.

Financial Disclosure:

None